Literature DB >> 25007799

About Dogs, Mice, and Men: From Ischemic Preconditioning to Anesthetic Postconditioning of the Heart.

Tobias Eckle1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25007799      PMCID: PMC4474773          DOI: 10.1177/1089253214542253

Source DB:  PubMed          Journal:  Semin Cardiothorac Vasc Anesth        ISSN: 1089-2532


× No keyword cloud information.
  9 in total

Review 1.  Ischemia and reperfusion--from mechanism to translation.

Authors:  Holger K Eltzschig; Tobias Eckle
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.

Authors:  Scott D Solomon; John J V McMurray; Marc A Pfeffer; Janet Wittes; Robert Fowler; Peter Finn; William F Anderson; Ann Zauber; Ernest Hawk; Monica Bertagnolli
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

3.  Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop.

Authors:  R A Kloner; R Bolli; E Marban; L Reinlib; E Braunwald
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

Review 4.  Myocardial ischemia reperfusion injury: from basic science to clinical bedside.

Authors:  Anja Frank; Megan Bonney; Stephanie Bonney; Lindsay Weitzel; Michael Koeppen; Tobias Eckle
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2012-02-23

Review 5.  Anesthetic cardioprotection: the role of adenosine.

Authors:  Stephanie Bonney; Kelly Hughes; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

6.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2014-01-21       Impact factor: 29.690

7.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

8.  The Role of Cyclooxygenase-1 and -2 in Sevoflurane-Induced Postconditioning Against Myocardial Infarction.

Authors:  Jan Stumpner; Tobias Tischer-Zeitz; Anja Frank; Christopher Lotz; Andreas Redel; Markus Lange; Franz Kehl; Norbert Roewer; Thorsten Smul
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2014-02-25

9.  Activation of mitochondrial large-conductance calcium-activated K+ channels via protein kinase A mediates desflurane-induced preconditioning.

Authors:  Andreas Redel; Markus Lange; Virginija Jazbutyte; Christopher Lotz; Thorsten M Smul; Norbert Roewer; Franz Kehl
Journal:  Anesth Analg       Date:  2008-02       Impact factor: 5.108

  9 in total
  3 in total

1.  ADORA2b Signaling in Cardioprotection.

Authors:  Jennifer Gile; Tobias Eckle
Journal:  J Nat Sci       Date:  2016

Review 2.  Circadian MicroRNAs in Cardioprotection.

Authors:  Yoshimasa Oyama; Colleen Marie Bartman; Jennifer Gile; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

3.  Differential Tissue-Specific Function of Adora2b in Cardioprotection.

Authors:  Seong-wook Seo; Michael Koeppen; Stephanie Bonney; Merit Gobel; Molly Thayer; Patrick N Harter; Katya Ravid; Holger K Eltzschig; Michel Mittelbronn; Lori Walker; Tobias Eckle
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.